[Specific immunotherapy using cell-mediated immune transfer factor. Preliminary results with semi-purified transfer factor].
D002177:Candidiasis / Q000628:therapy*; D006561:Herpes Simplex / Q000628:therapy*; D006801:Humans; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007167:Immunotherapy; D008214:Lymphocytes / Q000276:immunology; D008457:Measles / Q000628:therapy*; D011119:Polynucleotides / Q000302:isolation & purification / Q000627:therapeutic use; D013344:Subacute Sclerosing Panencephalitis / Q000628:therapy*
D011119:Polynucleotides
Immunothérapie adoptive spécifique par le facteur de transfert de l'immunité à médiation cellulaire. Résultats préliminaires d'un facteur de transfert semi-purifié.